|
"pei jer chen"的相關文件
顯示項目 656-705 / 883 (共18頁)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-07-03T03:33:26Z |
Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals
|
Liu C.-H.; Lee M.-H.; Lin J.-W.; Liu C.-J.; Su T.-H.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:25Z |
Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)
|
Chang F.-Y.; Chen H.-C.; PEI-JER CHEN; Ho M.-S.; Hsieh S.-L.; Lin J.-C.; Liu F.-T.; Sytwu H.-K. |
| 臺大學術典藏 |
2021-07-03T03:33:25Z |
Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection
|
Cheng X.; Uchida T.; Xia Y.; Umarova R.; Liu C.-J.; PEI-JER CHEN; Gaggar A.; Suri V.; M?cke M.M.; Vermehren J.; Zeuzem S.; Teraoka Y.; Osawa M.; Aikata H.; Tsuji K.; Mori N.; Hige S.; Karino Y.; Imamura M.; Chayama K.; Liang T.J. |
| 臺大學術典藏 |
2021-07-03T03:33:25Z |
2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population
|
Yu M.-L.; PEI-JER CHEN; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L. |
| 臺大學術典藏 |
2021-07-03T03:33:24Z |
Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in Taiwan
|
Lin G.-Y.; Wu Y.-L.; Wang C.-S.; Ko C.-Y.; Chen C.-H.; PEI-JER CHEN; Peng P.-H.; Hsu C.-W. |
| 臺大學術典藏 |
2021-07-03T03:33:24Z |
The origin and underlying driving forces of the SARS-CoV-2 outbreak
|
Chaw S.-M.; Tai J.-H.; Chen S.-L.; Hsieh C.-H.; Chang S.-Y.; Yeh S.-H.; Yang W.-S.; PEI-JER CHEN; Wang H.-Y. |
| 臺大學術典藏 |
2021-07-03T03:33:24Z |
Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing
|
Yang Y.-C.; Chen Y.-H.; Kao J.-H.; Ching C.; Liu I.-J.; Wang C.-C.; Tsai C.-H.; Wu F.-Y.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Yang H.-C. |
| 臺大學術典藏 |
2021-07-03T03:33:23Z |
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data
|
Hong C.-M.; Liu C.-H.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen Y.-W.; Kao J.-H.; Liu C.-J. |
| 臺大學術典藏 |
2021-07-03T03:33:23Z |
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations
|
Yu M.-L.; PEI-JER CHEN; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L. |
| 臺大學術典藏 |
2021-07-03T03:33:23Z |
The role of phylogenetic analysis in clarifying the infection source of a COVID-19 patient
|
Wang J.-T.; Lin Y.-Y.; Chang S.-Y.; Yeh S.-H.; Hu B.-H.; PEI-JER CHEN; Chang S.-C. |
| 臺大學術典藏 |
2021-07-03T03:33:23Z |
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer
|
Su T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; Liu C.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:22Z |
Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials
|
Asahina Y.; Liu C.-J.; Gane E.; Itoh Y.; Kawada N.; Ueno Y.; Youn J.; Wang C.-Y.; Llewellyn J.; Matsuda T.; Gaggar A.; Mo H.; Dvory-Sobol H.; Crans G.; Chuang W.-L.; PEI-JER CHEN; Enomoto N. |
| 臺大學術典藏 |
2021-07-03T03:33:22Z |
Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan
|
Su H.-J.; Kao J.-H.; Tseng T.-C.; Yang H.-C.; Su T.-H.; PEI-JER CHEN; Liu C.-J. |
| 臺大學術典藏 |
2021-07-03T03:33:22Z |
Disease burden from foodborne illnesses in Taiwan, 2012–2015
|
Lai Y.-H.; Chung Y.-A.; Wu Y.-C.; Fang C.-T.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:33:22Z |
Elimination of hepatitis B in highly endemic settings: Lessons learned in Taiwan and challenges ahead
|
Liu C.-J.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:33:21Z |
High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy
|
Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:21Z |
Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects
|
Cheng Y.-W.; Chao T.-L.; Li C.-L.; Chiu M.-F.; Kao H.-C.; Wang S.-H.; Pang Y.-H.; Lin C.-H.; Tsai Y.-M.; Lee W.-H.; Tao M.-H.; Ho T.-C.; Wu P.-Y.; Jang L.-T.; PEI-JER CHEN; Chang S.-Y.; Yeh S.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:20Z |
Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B-related hepatocellular carcinoma
|
Huang B.-Y.; Tsai M.-R.; Hsu J.-K.; Lin C.-Y.; Lin C.-L.; Hu J.-T.; Huang Y.-W.; Liu C.-J.; Wu W.-J.; Wu C.-F.; Sung F.-Y.; PEI-JER CHEN; Liang H.-J.; Lin S.-M.; Yu M.-W. |
| 臺大學術典藏 |
2021-07-03T03:33:20Z |
Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan
|
Liu C.-H.; Su T.-H.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:20Z |
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
|
Liu C.-H.; Peng C.-Y.; Fang Y.-J.; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:19Z |
Cell-Free Virus-Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer
|
Li C.-L.; Ho M.-C.; Lin Y.-Y.; Tzeng S.-T.; Chen Y.-J.; Pai H.-Y.; Wang Y.-C.; Chen C.-L.; Lee Y.-H.; Chen D.-S.; Yeh S.-H.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:33:19Z |
Ropeginterferon alfa-2b every 2?weeks as a novel pegylated interferon for patients with chronic hepatitis B
|
Huang Y.-W.; Hsu C.-W.; Lu S.-N.; Yu M.-L.; Su C.-W.; Su W.-W.; Chien R.-N.; Hsu C.-S.; Hsu S.-J.; Lai H.-C.; Qin A.; Tseng K.-C.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:33:18Z |
Autophagy restricts mitochondrial DNA damage-induced release of ENDOG (endonuclease G) to regulate genome stability
|
Chao T.; Shih H.-T.; Hsu S.-C.; PEI-JER CHEN; Fan Y.-S.; Jeng Y.-M.; Shen Z.-Q.; Tsai T.-F.; Chang Z.-F. |
| 臺大學術典藏 |
2021-07-03T03:33:18Z |
Chapter XX Antiviral Treatment and Cancer Control
|
Shih W.-L.; Fang C.-T.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:33:17Z |
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load
|
Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; PEI-JER CHEN; Kao J.-H. |
| 臺大學術典藏 |
2019-10-14T05:52:27Z |
Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus-Associated Hepatocellular Carcinoma
|
Li, Yung-Tsung;Wu, Hui-Lin;Jia-Horng Kao;Cheng, Huei-Ru;Ming-Chih Ho;Wang, Chih-Chiang;Pei-Jer Chen;Ding-Shinn Chen;Chun-Jen Liu; Li, Yung-Tsung; Wu, Hui-Lin; JIA-HORNG KAO; Cheng, Huei-Ru; MING-CHIH HO; Wang, Chih-Chiang; PEI-JER CHEN; DING-SHINN CHEN; CHUN-JEN LIU |
| 臺大學術典藏 |
2019-09-09T00:55:32Z |
Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Children With a Normal Alanine Aminotransferase Level
|
JIA-FENG WU;HUEY-LING CHEN;TUNG-HUNG SU;MEI-HWEI CHANG;PEI-JER CHEN;HONG-YUAN HSU;Chen, Ho Sheng;Xia, Ning Shao; Xia, Ning Shao; Chen, Ho Sheng; HONG-YUAN HSU; PEI-JER CHEN; MEI-HWEI CHANG; TUNG-HUNG SU; HUEY-LING CHEN; JIA-FENG WU |
| 臺大學術典藏 |
2019-08-30T02:53:54Z |
Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region
|
SHIOU-HWEI YEH;PEI-JER CHEN;DING-SHINN CHEN;MING-CHIH HO;Lin, You-Yu;Li, Chen-Yu;Li, Chiao-Ling; Li, Chiao-Ling; Li, Chen-Yu; Lin, You-Yu; MING-CHIH HO; DING-SHINN CHEN; PEI-JER CHEN; SHIOU-HWEI YEH |
| 臺大學術典藏 |
2019-08-29T07:36:15Z |
Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy
|
HUNG-CHIH YANG; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-JEN LIU;HUNG-CHIH YANG;Tseng, Tai-Chung;KAI-WEN HUANG;CHEN-HUA LIU;Liao, Chun-Hsun;TUNG-HUNG SU; TUNG-HUNG SU; Liao, Chun-Hsun; CHEN-HUA LIU; KAI-WEN HUANG; Tseng, Tai-Chung |
| 臺大學術典藏 |
2019-08-29T07:31:54Z |
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging
|
Tung-Hung Su;Liao, Sih-Han;Chun-Ming Hong;Chun-Jen Liu;Tseng, Tai-Chung;Chen-Hua Liu;Hung-Chih Yang;Pei-Jer Chen;Ding-Shinn Chen;Chi-Ling Chen;Adhoute, Xavier;Bourli?Re, Marc;Jia-Horng Kao; TUNG-HUNG SU; Liao, Sih-Han; CHUN-MING HONG; CHUN-JEN LIU; Tseng, Tai-Chung; CHEN-HUA LIU; HUNG-CHIH YANG; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; Adhoute, Xavier; Bourli?re, Marc; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:31:06Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou, Hsiao-Hui;Hung-Chih Yang;Hsiao, Chin-Fu;Hsiung, Chao A;Liu, Tsang-Wu;Chuang, Mei-Hsing;Wu, Hsiao-Yu;Hsu, Ya-Ting;Tsui, Chiung-Wen;Pei-Jer Chen;Ann-Lii Cheng;Hsu, Chiun; Tsou, Hsiao-Hui; HUNG-CHIH YANG; Hsiao, Chin-Fu; Hsiung, Chao A; Liu, Tsang-Wu; Chuang, Mei-Hsing; Wu, Hsiao-Yu; Hsu, Ya-Ting; Tsui, Chiung-Wen; PEI-JER CHEN; ANN-LII CHENG; Hsu, Chiun |
| 臺大學術典藏 |
2019-08-29T07:30:08Z |
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
|
Chen-Hua Liu;Tung-Hung Su;Chun-Jen Liu;Chun-Ming Hong;Hung-Chih Yang;Tseng, Tai-Chung;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao; CHEN-HUA LIU; TUNG-HUNG SU; CHUN-JEN LIU; CHUN-MING HONG; HUNG-CHIH YANG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:29:17Z |
Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection
|
JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:28:24Z |
Profile and value of FIB-4 in patients with dual chronic hepatitis C and B
|
Yang, Wan-Ting; TUNG-HUNG SU; HUNG-CHIH YANG; CHEN-HUA LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; Tseng, Tai-Chung; CHUN-JEN LIU; Chun-Jen Liu;Tseng, Tai-Chung;Yang, Wan-Ting;Tung-Hung Su;Hung-Chih Yang;Chen-Hua Liu;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao |
| 臺大學術典藏 |
2019-08-29T07:26:10Z |
Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma
|
JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-05T07:28:14Z |
Reduced toll-like receptor 9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy
|
JIA-HORNG KAO;Yang, Sien-Sing;PING-NING HSU;PEI-JER CHEN;DING-SHINN CHEN;Liang, Cher-Wei;Chang, Han-Yu;Hu, Jui-Ting;SHU-CHEN WEI;Lin, Shih-Chang;Hsu, Cheng-Kai;YI-WEN HUANG; YI-WEN HUANG; Hsu, Cheng-Kai; Lin, Shih-Chang; SHU-CHEN WEI; Hu, Jui-Ting; Chang, Han-Yu; Liang, Cher-Wei; DING-SHINN CHEN; PEI-JER CHEN; PING-NING HSU; Yang, Sien-Sing; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-05T07:20:11Z |
Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy
|
JIA-HORNG KAO;Yang, Sien-Sing;PING-NING HSU;PEI-JER CHEN;DING-SHINN CHEN;Huang, Shih-Hung;Chang, Han-Yu;Hu, Jui-Ting;SHU-CHEN WEI;Lin, Shih-Chang;YI-WEN HUANG; YI-WEN HUANG; Lin, Shih-Chang; SHU-CHEN WEI; Hu, Jui-Ting; Chang, Han-Yu; Huang, Shih-Hung; DING-SHINN CHEN; PEI-JER CHEN; PING-NING HSU; Yang, Sien-Sing; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-07-05T02:27:10Z |
Smoking and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase
|
MING-WHEI YU 于明暉;YI-WEN HUANG;MONG-HSUN TSAI;SHI-MING LIN;PEI-JER CHEN;YA-CHIEN YANG;CHUN-JEN LIU;Lin, Chih-Lin;Wu, Wan-Jung;Jan, Meng-Chin;Wu, Chih-Feng;YA-HUI CHUANG;Wang, Ya-Hui; Wang, Ya-Hui; YA-HUI CHUANG; Wu, Chih-Feng; Jan, Meng-Chin; Wu, Wan-Jung; Lin, Chih-Lin; CHUN-JEN LIU; YA-CHIEN YANG; PEI-JER CHEN; SHI-MING LIN; MONG-HSUN TSAI; YI-WEN HUANG; MING-WHEI YU |
| 臺大學術典藏 |
2019-02-27T06:48:01Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
Tseng, Tai-Chung;JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;CHEN-HUA LIU; CHEN-HUA LIU; CHUN-JEN LIU; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-02-27T06:44:06Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Tseng, Tai-Chung;Liu, Wen-Chun;Yang, Sheng-Shun;Chang, Chung-Hsin;Yang, Sien-Sing;Huang, Yi-Jie;JIA-HORNG KAO;CHIEN-CHING HUNG;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;HSIN-YUN SUN;CHEN-HUA LIU; CHEN-HUA LIU; Huang, Yi-Jie; Yang, Sien-Sing; Chang, Chung-Hsin; Yang, Sheng-Shun; HSIN-YUN SUN; CHUN-JEN LIU; Liu, Wen-Chun; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; CHIEN-CHING HUNG; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-02 |
Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region
|
Li, Chiao-Ling;Li, Chen-Yu;Lin, You-Yu;Ming-Chih Ho;Ding-Shinn Chen;Pei-Jer Chen;Shiou-Hwei Yeh; Li, Chiao-Ling; Li, Chen-Yu; Lin, You-Yu; MING-CHIH HO; SHIOU-HWEI YEH; PEI-JER CHEN; DING-SHINN CHEN |
| 臺大學術典藏 |
2018-09-10T18:07:01Z |
Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy
|
Tung-Hung Su;Chun-Hsun Liao;Chen-Hua Liu;Kai-Wen Huang;Tai-Chung Tseng;Hung-Chih Yang;Chun-Jen Liu;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:35:17Z |
Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.
|
Yang, Wan-Ting;Wu, Li-Wei;Tseng, Tai-Chung;Chen, Chi-Ling;Yang, Hung-Chih;Su, Tung-Hung;Wang, Chia-Chi;Kuo, Stephanie Fang-Tzu;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen;Kao, Jia-Horng; Wan-Ting Yang, Li-Wei Wu, Tai-Chung Tseng, Chi-Ling Chen, Hung-Chih Yang, Tung-Hung Su, Chia-Chi Wang, Stephanie Fang-Tzu Kuo, Chen-Hua Liu, Pei-Jer Chen, Ding-Shinn Chen, Chun-Jen Liu, Jia-Horng Kao; 劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳祈玲; HUNG-CHIH YANG; Yang, Wan-Ting; Wu, Li-Wei; CHUN-JEN LIU; Tseng, Tai-Chung; PEI-JER CHEN; Chen, Chi-Ling; CHEN-HUA LIU; DING-SHINN CHEN; Yang, Hung-Chih; TUNG-HUNG SU; Su, Tung-Hung; JIA-HORNG KAO; Wang, Chia-Chi; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:35:07Z |
Perspectives on dual hepatitis B and C infection in Taiwan
|
Liu, Chun-Jen; Liu, Chun-Jen; CHUN-JEN LIU; PEI-JER CHEN; Chen, Pei-Jer; Chen, Pei-Jer; DING-SHINN CHEN; Chen, Ding-Shinn; JIA-HORNG KAO; Tseng, Tai-Chung; Kao, Jia-Horng; Kao, Jia-Horng; Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Tseng, Tai-Chung;Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:32:52Z |
Progressive accumulation of mutations in the hepatitis B virus genome and its impact for time to diagnosis of hepatocellular carcinoma
|
Sung, Feng-Yu;Lan, Chia-Ying;Huang, Chi-Jung;Lin, Chih-Lin;Liu, Chun-Jen;Chen, Pei-Jer;Lin, Shi-Ming;Yu, Ming-Whei; Sung, Feng-Yu; MING-WHEI YU; Sung, Feng-Yu; CHUN-JEN LIU; Lan, Chia-Ying; PEI-JER CHEN; Huang, Chi-Jung; Lin, Chih-Lin; Lin, Chih-Lin; Liu, Chun-Jen; Liu, Chun-Jen; Chen, Pei-Jer; Lin, Shi-Ming; Lin, Shi-Ming; Yu, Ming-Whei; Yu, Ming-Whei |
| 臺大學術典藏 |
2018-09-10T15:32:52Z |
The Hepatitis Viral Status in Patients with Hepatocellular Carcinoma: A Study of 3843 Patients from Taiwan Liver Cancer Network
|
Chang, Il-Chi;Huang, Shiu-Feng;Chen, Pei-Jer;Chen, Chi-Ling;Chen, Chao-Long;Wu, Cheng-Chung;Tsai, Cheng-Chung;Lee, Po-Huang;Chen, Miin-Fu;Lee, Chuan-Mo;Yu, Hsien-Chung;Lo, Gin-Ho;Yeh, Chau-Ting;Hong, Chih-Chen;Eng, Hock-Liew;Wang, John;Tseng, Hui-Hwa;Hsiao, Cheng-Hsiang;Wu, Hong-Dar Isaac;Yen, Tseng-Chang;Liaw, Yun-Fan; Chang, I.-C. and Huang, S.-F. and Chen, P.-J. and Chen, C.-L. and Chen, C.-L. and Wu, C.-C. and Tsai, C.-C. and Lee, P.-H. and Chen, M.-F. and Lee, C.-M. and Yu, H.-C. and Lo, G.-H. and Yeh, C.-T. and Hong, C.-C. and Eng, H.-L. and Wang, J. and Tseng, H.-H. and Hsiao, C.-H. and Wu, H.-D.I. and Yen, T.-C. and Liaw, Y.-F.; 蕭正祥;陳培哲;李伯皇;陳祈玲; Chang, Il-Chi; PEI-JER CHEN; Huang, Shiu-Feng; Chen, Pei-Jer; Chen, Chi-Ling; Chen, Chao-Long; Wu, Cheng-Chung; Tsai, Cheng-Chung; Lee, Po-Huang; Chen, Miin-Fu; Lee, Chuan-Mo; Yu, Hsien-Chung; Lo, Gin-Ho; Yeh, Chau-Ting; Hong, Chih-Chen; Eng, Hock-Liew; Wang, John; Tseng, Hui-Hwa; Hsiao, Cheng-Hsiang; Wu, Hong-Dar Isaac; Yen, Tseng-Chang; Liaw, Yun-Fan |
| 臺大學術典藏 |
2018-09-10T15:27:32Z |
Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping
|
Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, C.-H. and Liang, C.-C. and Liu, C.-J. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; HUNG-CHIH YANG; Liu, Chen-Hua; Liang, Cheng-Chao; CHUN-JEN LIU; PEI-JER CHEN; Liu, Chun-Jen; CHEN-HUA LIU; Lin, Chih-Lin; Su, Tung-Hung; DING-SHINN CHEN; Yang, Hung-Chih; TUNG-HUNG SU; JIA-HORNG KAO; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:27:22Z |
Development of risk scoring system for stratifying population for hepatocellular carcinoma screening.
|
CHUN-JEN LIU; PEI-JER CHEN; HUNG HUNG; Lin, Shi-Ming; Lee, Shou-Dong; Chuang, Shu-Chun; Yu, Ming-Whei; Hung, Yi-Chun;Lin, Chih-Lin;Liu, Chun-Jen;Hung, Hung;Lin, Shi-Ming;Lee, Shou-Dong;Chen, Pei-Jer;Chuang, Shu-Chun;Yu, Ming-Whei; Hung, Yi-Chun; MING-WHEI YU; Lin, Chih-Lin |
| 臺大學術典藏 |
2018-09-10T15:26:55Z |
Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection
|
Tseng, T.-C. and Liu, C.-J. and Chen, C.-L. and Yang, W.-T. and Yang, H.-C. and Su, T.-H. and Wang, C.-C. and Kuo, S.F.-T. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; Tseng, T. -C.;Liu, C. -J.;Chen, C. -L.;Yang, W. -T.;Yang, H. -C.;Su, T. -H.;Wang, C. -C.;Kuo, S. F. -T.;Liu, C. -H.;Chen, P. -J.;Chen, D. -S.;Kao, J. -H.; Tseng, T. -C.;Liu, C. -J.;Chen, C. -L.;Yang, W. -T.;Yang, H. -C.;Su, T. -H.;Wang, C. -C.;Kuo, S. F. -T.;Liu, C. -H.;Chen, P. -J.;Chen, D. -S.;Kao, J. -H.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;陳祈玲; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;陳祈玲; Chang, C-H.; Tseng, T. -C.; HUNG-CHIH YANG; CHUN-JEN LIU; Liu, C. -J.; PEI-JER CHEN; Chen, C. -L.; Yang, W. -T.; CHEN-HUA LIU; TUNG-HUNG SU; Yang, H. -C.; DING-SHINN CHEN; Su, T. -H.; Wang, C. -C.; JIA-HORNG KAO; Kuo, S. F. -T.; Liu, C. -H.; Chen, P. -J.; Chen, D. -S.; Kao, J. -H. |
| 臺大學術典藏 |
2018-09-10T15:25:10Z |
Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota
|
Chou, Han-Hsuan;Chien, Wei-Hung;Wu, Li-Ling;Cheng, Chi-Hung;Chung, Chen-Han;Horng, Jau-Haw;Ni, Yen-Hsuan;Tseng, Hong-Tai;Wu, Dafei;Lu, Xuemei;Wang, Hurng-Yi;Chen, Pei-Jer;Chen, Ding-Shinn; Chou, H.-H. and Chien, W.-H. and Wu, L.-L. and Cheng, C.-H. and Chung, C.-H. and Horng, J.-H. and Ni, Y.-H. and Tseng, H.-T. and Wu, D. and Lu, X. and Wang, H.-Y. and Chen, P.-J. and Chen, D.-S.; 陳定信;倪衍玄;陳培哲;王弘毅; PEI-JER CHEN; Chou, Han-Hsuan; Chien, Wei-Hung; HURNG-YI WANG; DING-SHINN CHEN; Wu, Li-Ling; Yen-Hsuan Ni; Cheng, Chi-Hung; Chung, Chen-Han; Horng, Jau-Haw; Ni, Yen-Hsuan; Tseng, Hong-Tai; Wu, Dafei; Lu, Xuemei; Wang, Hurng-Yi; Chen, Pei-Jer; Chen, Ding-Shinn |
顯示項目 656-705 / 883 (共18頁)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
每頁顯示[10|25|50]項目
|
